Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study
NCT02489773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2019-11-21
Summary
To confirm that Lucica ® Glycated Albumin-L is useful for the intermediate term (preceding 2-3 weeks) monitoring of glycemic control in patients with diabetes.
Conditions
Sponsors & Collaborators
-
Asahi Kasei Pharma Corporation
lead INDUSTRY
Principal Investigators
-
Hideji Hiraoka, M.S. · Diagnostics Department, Asahi Kasei Pharma
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- United States
Study Locations
More Related Trials
-
Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers
NCT02968498 ·Status: COMPLETED ·Phase: NA
-
Multicentre LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness (LOGIC-2)
NCT02056353 ·Status: COMPLETED ·Phase: NA
-
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)
NCT00500240 ·Status: TERMINATED ·Phase: PHASE3
-
Enteral Nutrition and Glucose Homeostasis
NCT03012867 ·Status: COMPLETED ·Phase: PHASE4
-
Liver Glycogen and Hypoglycemia in Humans
NCT03241706 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Admission HbA1C in Aneurysmal Subarachnoid Hemorrhage
NCT02081820 ·Status: COMPLETED
-
Tight Glycemic Control With Intensive Insulin Therapy in PICU
NCT00214916 ·Status: UNKNOWN ·Phase: PHASE2
-
Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke
NCT02054429 ·Status: COMPLETED ·Phase: PHASE1
-
HbA1c and Outcomes in the Critically Ill
NCT02822976 ·Status: COMPLETED
-
Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
NCT00943709 ·Status: WITHDRAWN ·Phase: PHASE3
-
Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
NCT04876079 ·Status: COMPLETED ·Phase: NA
-
Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients
NCT03665207 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit
NCT00166491 ·Status: COMPLETED ·Phase: NA
-
Acute Haemodynamic Impact of an IV Glucose-injection
NCT00426114 ·Status: WITHDRAWN ·Phase: PHASE2
-
Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA
NCT00920725 ·Status: COMPLETED ·Phase: NA
-
Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay
NCT02278913 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Anti Diabetic Agents in the Hospital
NCT04416269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study
NCT01463878 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin Therapy
NCT02503527 ·Status: TERMINATED ·Phase: NA
-
Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients
NCT00735163 ·Status: COMPLETED ·Phase: NA
-
LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness
NCT01420302 ·Status: COMPLETED ·Phase: NA
-
Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.
NCT02244073 ·Status: TERMINATED ·Phase: NA
-
GlucoClear ICU Study
NCT02238041 ·Status: WITHDRAWN
-
Glycemic Control in Diabetic Hospitalized Patients
NCT04800861 ·Status: COMPLETED
-
Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care
NCT03802942 ·Status: UNKNOWN ·Phase: PHASE3